Their findings indicate that FKA inhibits the migration, invasion, VM formation, and EMT progression of HCC cells by targeting CXCL12, thereby suppressing the PI3K/Akt/HIF-1α/Twist1 pathway (72). Here, CXCL12 is linked to hepatocellular carcinoma.